Pharma & Healthcare

Strong demand outlook in domestic and global markets posits India’s Pharma and Healthcare Industry at an inflection point. Axis Capital is able to contribute strongly to corporate value creation as the segment gets a fillip from growth in innovation, realignment in global supply chains and favourable regulatory support.

Segments

  • Hospitals
  • Pharma Value Chain (Intermediates, API, Formulations)
  • Biopharmaceuticals (Biologics, Biosimilars)
  • Outsourcing (CRO, CDMO, CMO)

Transactions

  • Transaction Image
    Akums drugs &
    pharmaceuticals ltd.
    1,857 Mn

    IPO Jul 2024

  • Transaction Image
    Alkem labs
    487 Mn

    Block Aug 2024

  • Transaction Image
    Emcure pharmaceuticals
    ltd.
    1,952 Mn

    IPO Jul 2024

  • Transaction Image
    Alkem labs
    990 Mn

    Block Jun 2024

  • Transaction Image
    Alkem labs
    446 Mn

    Block Aug 2023

  • Transaction Image
    Mankind pharma ltd.
    4,326 Mn

    IPO Apr 2023

  • Transaction Image
    Supriya lifesciences ltd
    700 Mn

    IPO Dec 2021

  • Transaction Image
    Medplus health services
    ltd
    1,398 Mn

    IPO Dec 2021

  • Transaction Image
    Medplus
    5,500 Mn

    Fund Raise Dec 2021

  • Transaction Image
    Supriya lifescience
    limited
    7,000 Mn

    IPO Dec 2021

  • Transaction Image
    Medplus health services
    limited
    13,980 Mn

    IPO Dec 2021

  • Transaction Image
    Ami organics limited
    5,700 Mn

    IPO Sep 2021

  • Transaction Image
    Chemplast sanmar limited
    38,500 Mn

    IPO Aug 2021

  • Transaction Image
    Clean science and
    technology limited
    15,470 Mn

    IPO Jul 2021

  • Transaction Image
    Krishna institute of
    medical science ltd
    2,144 Mn

    IPO Jun 2021

  • Transaction Image
    India pesticides limited
    8,000 Mn

    IPO Jun 2021

  • Transaction Image
    Krishna institute of
    medical sciences limited
    21,440 Mn

    IPO Jun 2021

  • Transaction Image
    Laxmi organic industries
    6,000 Mn

    IPO Mar 2021


Axis Capital’s pharma & healthcare practice is led by

  • No Image
    Ujjwal Singh Managing Director

    Ujjwal leads pharma and healthcare coverage for Axis Capital. He has 19 years of experience in investment banking across M&A, debt, capital markets and private equity financing. He has previously worked with organizations like Avendus, JM Financial, Motilal Oswal and Citibank. Ujjwal has an MBA degr...

;
How can we help you?

Reach out to discover how India’s leading investment bank can help you reach your financial and strategic goals.

Connect with us
;
© All rights reserved by Axis Capital 2025.